Compounding Pharmacy Peptide Procurement: A Step-by-Step Workflow

For compounding pharmacies entering or expanding peptide programs, a structured procurement workflow ensures regulatory compliance, quality consistency, and operational efficiency. This guide provides a step-by-step framework from initial supplier identification through ongoing quality monitoring.

Step 1: Define Your Peptide Formulary

Before sourcing, define which peptides your pharmacy will compound. Consider: clinical demand from your prescriber base, regulatory eligibility (Category 1 status for each compound), your pharmacy's compounding capabilities (sterile vs. non-sterile, equipment, staff training), and stability and beyond-use dating requirements.

Start with 3-5 high-demand peptides rather than trying to stock every available compound. Common starting formularies include: semaglutide (weight management), BPC-157 (tissue repair), NAD+ (cellular health), and one or two GH secretagogues (CJC-1295, Ipamorelin).

Step 2: Supplier Identification and Initial Screening

Identify potential API suppliers through: industry directories, trade show contacts, industry peer recommendations, and manufacturer direct outreach. Screen candidates against basic criteria: GMP certification, FDA registration status, peptide-specific manufacturing experience, and willingness to provide documentation promptly.

Step 3: Supplier Qualification

For suppliers that pass initial screening, conduct formal qualification following the framework in our GMP Sourcing Guide. Key steps: documentation review (GMP certificates, DMF status, COA samples, stability data), evaluation sample ordering and independent testing, reference checks with other pharmaceutical buyers, and Quality Technical Agreement (QTA) negotiation.

Step 4: Procurement and Receiving

Establish a standard procurement process: generate purchase orders with complete specifications (compound, quantity, purity, documentation requirements), confirm lead times and shipping conditions, receive materials into quarantine (not available for use until released), perform incoming inspection (verify packaging integrity, labeling, temperature monitoring), and log receipt in your inventory management system.

Step 5: Incoming Quality Testing

Every incoming lot should undergo at minimum identity testing to confirm the material is the correct compound. Your incoming testing protocol should define: which tests are performed (identity, purity, endotoxin, etc.), acceptance criteria for each test, procedures for out-of-specification results, and documentation requirements.

For detailed testing guidance: COA Verification Guide

Step 6: Material Release and Compounding

Once incoming testing is complete and all acceptance criteria are met, release the material from quarantine for compounding use. Document the release decision with the reviewer's name, date, and reference to supporting test data. Maintain full traceability from the API lot number through each compounded batch.

Step 7: Ongoing Supplier Monitoring

Track supplier performance over time: batch-to-batch consistency, on-time delivery, documentation quality, and responsiveness. Review quarterly and conduct annual business reviews with key suppliers. Use a scorecard system that provides objective data for supplier management decisions.

For regulatory compliance requirements: Regulatory Compliance Guide